A Trial of ABI-007 in Patients With Advanced Non-Hematologic Malignancies

Clinical trial NCT00046423 · COMPLETED

Trial details

NCT number: NCT00046423
Sponsor: Celgene Corporation
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Neoplasms Metastases, Neoplasm

Start date: 2000-04-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.